MIR548AA1: A Potential Drug Target and Biomarker (G100500863)

Target Name: MIR548AA1

NCBI ID: G100500863

MIR548AA1

Other Name(s): MicroRNA 548aa-1 | microRNA 548aa-1 | hsa-mir-548aa-1 | hsa-miR-548aa

MIR548AA1: A Potential Drug Target and Biomarker

MIR548AA1, also known as interleukin-5 receptor antagonist A, is a protein that is expressed in various tissues throughout the body, including the lungs, heart, kidneys, and central nervous system. It is a member of the interleukin-5 receptor family, which is a protein that is involved in the regulation of immune and inflammatory responses.

Recent studies have identified MIR548AA1 as a potential drug target and biomarker for various diseases, including cancer, asthma, and chronic obstructive pulmonary disease (COPD). MIR548AA1 has also been shown to play a role in the regulation of inflammation, which is a crucial aspect of many diseases.

One of the key benefits of MIR548AA1 as a drug target is its potential to disrupt the activity of immune cells that are involved in cancer growth and development. MIR548AA1 has been shown to inhibit the activity of T cells, which are a type of immune cell that play a critical role in the regulation of cancer growth.

In addition to its potential as a cancer drug, MIR548AA1 has also been shown to be a potential biomarker for various diseases. For example, MIR548AA1 has been shown to be elevated in the blood samples of people with lung cancer, which suggests that it may be a useful biomarker for this disease.

Another potential application of MIR548AA1 as a drug target is its potential to treat respiratory diseases, such as asthma and COPD. MIR548AA1 has been shown to improve the function of airways in people with these conditions, which could lead to improved symptoms and quality of life.

In addition to its potential as a drug target and biomarker, MIR548AA1 has also been shown to play a critical role in the regulation of inflammation. Studies have shown that MIR548AA1 is involved in the regulation of the activation and function of immune cells, which is crucial for the regulation of inflammatory responses.

Overall, MIR548AA1 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role and potential applications in these fields.

Protein Name: MicroRNA 548aa-1

The "MIR548AA1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548AA1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets